26 /100
MEDIUM RISK
Score updated May 30, 2026

ENTA — Enanta Pharmaceuticals, Inc. Dilution Risk Tracker

Track ENTA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ENTA — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
7%
📉 Score Deterioration 15%
• Score climbed 5 points (worsening)
🔔 Track ENTA — Get forecast alerts →

💹 Market Data

Market Cap$382.67M
Shares Outstanding29.08M
Float20.06M
Cash$163.77M
Debt$186.62M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 45.6% shares (2025Q4 vs prior)
132 institutional holders · 28.78M shares
#1 FARALLON CAPITAL MANAGEMENT LLC 4.89M shares
#2 JANUS HENDERSON GROUP PLC 3.73M shares
#3 BlackRock, Inc. 3.08M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2.20M
Days to Cover9.4
% of Float11.0%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Sep 30, 2013
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track ENTA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ENTA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for ENTA
📊 ENTA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ENTA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.